Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Moleculin Biotech Announces Pricing Of Public Offering For 2.47M Shares, Series A And B Warrants At $2.23 Per Share

Author: Benzinga Newsdesk | August 16, 2024 08:04am

Warrants Exercisable Upon Shareholder Approval With Series A Expiring In 2 Years And Series B In 5 Years, Subject To Interim And Final Data From MIRACLE Trial; Closing Expected Around August 19, 2024

Posted In: MBRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist